MedTrace Logo

Beneficial Bacteria to Prevent Malnutrition and Diarrhea in Pakistani Infants

NCT00118872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-09-04

No results posted yet for this study

Summary

This study will determine whether lactobacillus GG (LGG), a beneficial bacterium, when given in yogurt, will reduce growth faltering in babies living in a poor area of Pakistan who are being weaned from breastfeeding.

Study hypothesis: Use of the probiotic bacteria LGG at the time of weaning will lessen the impact of faltering growth in babies living in the slums of Pakistan.

Conditions

Interventions

DRUG

LGG yogurt

Lactobacillus GG containing yogurt

OTHER

Placebo yogurt

Yogurt NOT containing the active LGG bacteria

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Tufts University

    lead OTHER

Principal Investigators

  • Christine A. Wanke, MD · Tufts University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Week
Max Age
5 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2007-12-31
Completion
2008-03-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00118872 on ClinicalTrials.gov